Ann Arbor, MI, United States of America

Hongwei Chen

This inventor holds 8 USPTO granted patents and 4 published patent applications. Top assignees: University of Michigan, Imra of America, Inc.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hongwei Chen. Retrieved from https://idiyas.com/inventor/hongwei-chen-zljlbgl6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 87.5

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2016-2026

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Hongwei Chen

Introduction

Hongwei Chen is a prominent inventor based in Ann Arbor, MI. He has made significant contributions to the field of nanotechnology, particularly in the development of nano-satellite complexes aimed at enhancing cancer treatment. With a total of seven patents to his name, Chen's work is at the forefront of innovative medical solutions.

Latest Patents

Chen's latest patents include groundbreaking inventions such as nano-satellite complexes. These complexes consist of a core nanoparticle complex with a biocompatible coating surrounding a nanoparticle core, along with satellite particles and antigenic peptides. His inventions aim to achieve long-term cancer remission, especially when combined with immune checkpoint inhibitors. Another notable patent involves complexes for the delivery of antigenic peptides, which are designed to modulate antigen-specific immune responses and enhance anti-tumor immunity.

Career Highlights

Throughout his career, Hongwei Chen has worked with esteemed organizations such as the University of Michigan and Imra of America, Inc. His research has significantly advanced the understanding and application of nanotechnology in medicine.

Collaborations

Chen has collaborated with notable colleagues, including Duxin Sun and Kanokwan Sansanaphongpricha, contributing to the innovative research landscape in his field.

Conclusion

Hongwei Chen's contributions to nanotechnology and cancer treatment exemplify the impact of innovative thinking in medicine. His patents reflect a commitment to advancing healthcare solutions through scientific research and collaboration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…